Zacks Investment Management Fibrogen Inc Transaction History

Zacks Investment Management

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$31.0 - $55.72 $498,883 - $896,701	-16,093 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $46,473 - $61,359	-1,253 Reduced 7.22%	16,093 $597,000
Q3 2020 Nov 16, 2020	SELL	$40.47 - $45.5 $37,515 - $42,178	-927 Reduced 5.07%	17,346 $713,000
Q2 2020 Aug 14, 2020	SELL	$32.57 - $42.83 $115,884 - $152,389	-3,558 Reduced 16.3%	18,273 $741,000
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $240,619 - $474,628	-10,327 Reduced 32.11%	21,831 $759,000
Q4 2019 Feb 14, 2020	BUY	$34.58 - $48.06 $301,330 - $418,794	8,714 Added 37.17%	32,158 $1.38 Million
Q3 2019 Nov 14, 2019	SELL	$36.98 - $48.45 $118,262 - $154,943	-3,198 Reduced 12.0%	23,444 $867,000
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $25,925 - $40,981	738 Added 2.85%	26,642 $1.2 Million
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $35,506 - $49,665	829 Added 3.31%	25,904 $1.41 Million
Q4 2018 Feb 14, 2019	BUY	$37.97 - $60.16 $952,097 - $1.51 Million	25,075 New	25,075 $1.16 Million
Q2 2018 Aug 14, 2018	SELL	$44.9 - $64.95 $477,870 - $691,262	-10,643 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$45.35 - $61.65 $12,834 - $17,446	-283 Reduced 2.59%	10,643 $492,000
Q4 2017 Feb 14, 2018	BUY	$41.95 - $60.1 $118,131 - $169,241	2,816 Added 34.72%	10,926 $518,000
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $270,874 - $437,129	8,110	8,110 $436,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.